Murray Korc

Affiliations: 
Pharmacology and Toxicology Dartmouth College, Hanover, NH, United States 
Area:
Pharmacology, Biochemistry, General
Google:
"Murray Korc"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Korc M. (2023) Heparin Prowess: Favorable Vascular-Immune Reprogramming in Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Sasaki N, Gomi F, Yoshimura H, et al. (2020) FGFR4 Inhibitor BLU9931 Attenuates Pancreatic Cancer Cell Proliferation and Invasion While Inducing Senescence: Evidence for Senolytic Therapy Potential in Pancreatic Cancer. Cancers. 12
Kornmann M, Lopez M, Beger H, et al. (2019) Expression of the IIIc Variant of FGF Receptor-1 Confers Mitogenic Responsiveness to Heparin and FGF-5 in TAKA-1 Pancreatic Ductal Cells. International Journal of Gastrointestinal Cancer. 29: 85-92
McElyea S, Korc M. (2019) Abstract C31: The glycosaminoglycan syndecan-4 facilitates pancreatic cancer progression and biologic aggressiveness Cancer Research. 79
Lin CC, Korc M. (2018) Designer hydrogels: Shedding light on the physical chemistry of the pancreatic cancer microenvironment. Cancer Letters
Korc M. (2018) Beyond Kras: MYC Rules in Pancreatic Cancer. Cellular and Molecular Gastroenterology and Hepatology. 6: 223-224
Danilov AV, Neupane D, Nagaraja AS, et al. (2018) Correction: DeltaNp63alpha-Mediated Induction of Epidermal Growth Factor Receptor Promotes Pancreatic Cancer Cell Growth and Chemoresistance. Plos One. 13: e0192927
Ouyang H, Gore J, Deitz S, et al. (2017) microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions. Oncogene
Prabhu L, Wei H, Chen L, et al. (2017) Adapting AlphaLISA high throughput screen to discover a novel small-molecule inhibitor targeting protein arginine methyltransferase 5 in pancreatic and colorectal cancers. Oncotarget
Lai X, Wang M, McElyea SD, et al. (2017) A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer. Cancer Letters
See more...